| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.57▼ | 5.61▼ | 5.61▼ | 5.97▼ | 5.94▼ |
| MA10 | 5.59▼ | 5.63▼ | 5.58▼ | 5.89▼ | 6.06▼ |
| MA20 | 5.61▼ | 5.58▼ | 5.74▼ | 6.07▼ | 6.85▼ |
| MA50 | 5.63▼ | 5.96▼ | 5.83▼ | 6.14▼ | 6.21▼ |
| MA100 | 5.58▼ | 5.84▼ | 6.00▼ | 6.84▼ | 5.23▲ |
| MA200 | 5.75▼ | 6.03▼ | 5.98▼ | 6.78▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.009▼ | 0.021▲ | -0.012▼ | -0.030▼ | -0.206▼ |
| RSI | 31.415▼ | 39.272▼ | 41.180▼ | 42.707▼ | 41.158▼ |
| STOCH | 8.464▼ | 46.970 | 57.549 | 46.895 | 25.207 |
| WILL %R | -95.455▼ | -50.000 | -78.289▼ | -75.515▼ | -86.013▼ |
| CCI | -107.891▼ | -29.713 | -58.643 | -108.348▼ | -57.329 |
|
Saturday, February 07, 2026 10:00 AM
Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that Ascletis ...
|
|
Thursday, February 05, 2026 04:24 AM
Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that ...
|
|
Tuesday, February 03, 2026 02:44 AM
US clinical-stage biotech Sagimet Biosciences' shares rose 10% to $6.23 after it announced that China-based partner Ascletis Pharma reported positive top-line results in the open-label Phase III trial ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 06/02/26 | 5.58 | 5.72 | 5.365 | 5.55 | 772,267 |
| 05/02/26 | 6.08 | 6.16 | 5.385 | 5.44 | 719,564 |
| 04/02/26 | 6.61 | 6.67 | 5.945 | 6.08 | 929,599 |
| 03/02/26 | 6.80 | 7.20 | 6.41 | 6.56 | 1,882,615 |
| 02/02/26 | 5.69 | 6.34 | 5.63 | 6.23 | 829,842 |
| 30/01/26 | 5.24 | 5.81 | 5.05 | 5.67 | 1,025,479 |
| 29/01/26 | 5.65 | 5.79 | 5.015 | 5.36 | 3,678,134 |
| 28/01/26 | 6.11 | 6.15 | 5.85 | 5.855 | 387,986 |
| 27/01/26 | 5.99 | 6.14 | 5.9274 | 6.09 | 272,078 |
| 26/01/26 | 6.12 | 6.14 | 5.88 | 6.03 | 561,958 |
|
|
||||
|
|
||||
|
|